Avidity Biosciences has set February 12, 2026, as the record date for the pro rata distribution of all issued and outstanding shares of Atrium Therapeutics, Inc. to holders of Avidity common stock. This distribution is part of the proposed acquisition of Avidity by Novartis AG and involves the separation of Avidity's early-stage precision cardiology programs into SpinCo. Shareholders of Avidity on the record date will receive one share of SpinCo common stock for every ten shares of Avidity common stock held.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avidity Biosciences Inc. published the original content used to generate this news brief on February 02, 2026, and is solely responsible for the information contained therein.